- Home
- FMY vs BEAT Comparison
FMY vs BEAT Comparison
Compare FMY & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMY | BEAT |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Finance/Investors Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 53.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FMY | BEAT |
|---|---|---|
| Price | $11.61 | $0.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 3.5K | ★ 610.9K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 6.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.40 | $0.54 |
| 52 Week High | $12.39 | $4.00 |
Technical Indicators
Market Signals| Indicator | FMY | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 41.90 |
| Support Level | $11.41 | $0.81 |
| Resistance Level | $12.29 | $1.28 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 84.86 | 5.62 |
Price Performance
Historical ComparisonAbout FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.